SaveHealth explores the potential prescription cost savings that can be achieved by leveraging cash prices and discount cards, providing insights based on real-world drug pricing data.
In more than half of the 50 largest U.S. metros, median list prices have plunged year over year—with San Francisco leading the way with a 10.87% decrease, according to the Realtor.com® December ...
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.
The report from AARP Public Policy Institute said average list prices on these 25 drugs have nearly doubled since they hit the market and collectively cost Medicare ‒ and American taxpayers ...
Drugmakers raised the list prices on 575 name-brand drugs in just the first two days of the new year, according to drug price research firm 46brooklyn. Drugs for diabetes, HIV, cancer saw price ...
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback